Company
Beam Therapeutics Inc.
BEAM · CIK 0001745999
Acquisition (code M) of 25,000 shares at $1.03 per share.
Reporting Person Evans John M. · Officer Title CEO · Transaction Code M
Traded Oct 16, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →
Sale of 25,000 shares at $23.9838 per share.
Reporting Person Evans John M. · Officer Title CEO · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →
Acquisition (code M) of 25,000 shares at $1.03 per share.
Reporting Person Evans John M. · Officer Title CEO · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →
Sale of 25,000 shares at $23.5660 per share.
Reporting Person Evans John M. · Officer Title CEO · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →
Sale of 187 shares at $24.41 per share.
Reporting Person Cavanagh Bethany J · Officer Title SVP, Finance and Treasurer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001193125-26-412236 · filed 2026-10-02 · View filing →